SCHEMBL725465

SCHEMBL725465

COc1ccc(-c2cc3nccc(-c4cnn(CCO)c4)c3o2)c(OC)c1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 5/20 0.39
TTK P33981 2/20 0.38
CSF1R P07333 2/20 0.38
PRKAB2 O43741 1/20 0.38
ABL1 P00519 1/20 0.38
LYN P07948 1/20 0.38
PRKAG1 P54619 1/20 0.38
SIK1 P57059 1/20 0.38
PRKAA1 Q13131 1/20 0.38
SIK2 Q9H0K1 1/20 0.38
SIK3 Q9Y2K2 1/20 0.38
PDE10A Q9Y233 1/20 0.37
PDK2 Q15119 1/20 0.36
FGFR3 P22607 5/20 0.35
FGFR1 P11362 4/20 0.35
KDR P35968 3/20 0.35
FGFR2 P21802 2/20 0.35
FGFR4 P22455 2/20 0.35
PDE4C Q08493 1/20 0.35
FEN1 P39748 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10266954 0.89 PDE4C (0.42) METTTKCSF1RPRKAB2ABL1
SCHEMBL725161 0.79 PDE4C (0.42) METTTKPDE4CFEN1IKBKE
SCHEMBL15209542 0.79 MET (0.40) METTTKCSF1RPRKAB2ABL1
SCHEMBL722554 0.78 KDM4E (0.44) PDE4C
SCHEMBL721506 0.78 PDE4C (0.39) CSF1RPRKAB2ABL1LYNPRKAG1
SCHEMBL723546 0.76 JAK2 (0.44) CSF1RPRKAB2PRKAG1PRKAA1FGFR3
SCHEMBL724725 0.75 PRKAB2 (0.42) CSF1RPRKAB2ABL1LYNPRKAG1
SCHEMBL722258 0.75 JAK2 (0.39) TTKFGFR3FGFR1KDRFGFR2
SCHEMBL722228 0.74 PDE4C (0.43) METTTKPDE4CSYK
SCHEMBL723668 0.74 PGK1 (0.41) PDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP claimed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO claimed